Experimental cutaneous pain thresholds and tolerance in clinical analgesia with epidural morphine.
Ten patients experiencing significant analgesia from repeated low-dose morphine injections via an indwelling epidural catheter were studied. One group (n = 5) with acute, postoperative pain was tested for changes in experimental cutaneous pain thresholds with and without clinical morphine analgesia. Three of these patients received intravenous naloxone. The analgesia was reversed in two. There was no significant alteration in any cutaneous modality, including pain, although the postoperative deep pain was relieved. This discrepancy might be explained by the existence of separate subpopulations of opiate receptors at the spinal cord level, which differentiate nociceptive input from the skin and from deep body structures. The other group (n = 5) of cancer pain patients with a permanent epidural catheter was monitored for long-term changes in clinical pain. Signs of tolerance were not seen with an observation period up to 6 weeks.
D000368:Aged; D000767:Anesthesia, Epidural; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009020:Morphine; D010146:Pain / Q000503:physiopathology*; D010148:Intractable Pain / Q000175:diagnosis / Q000628:therapy; D010149:Postoperative Pain / Q000175:diagnosis / Q000628:therapy; D012684:Sensory Thresholds
D009020:Morphine